Liver Metastases News

Dr. Ross on Biomarker Research Development in Liver Metastasis - OncLive



Dr. Ross on Biomarker Research Development in Liver Metastasis 
OncLive
Merrick I. Ross, MD, professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, discusses biomarker research development for patients with liver metastases. The most important unmet challenge ...

and more » 


MRI potentially more cost-effective than CT for imaging liver metastases - Health Imaging



MRI potentially more cost-effective than CT for imaging liver metastases 
Health Imaging
Contrast-enhanced MRI is more sensitive than contrast-enhanced CT for diagnosing liver metastases in patients with known colorectal cancer. What's more, while it's pricier, the MRI option can also be cost-effective, delivering returns on investment in ...

 


Pancreatic Neuroendocrine Tumors: State-of-the-Art Diagnosis and Management - Cancer Network



Pancreatic Neuroendocrine Tumors: State-of-the-Art Diagnosis and Management 
Cancer Network
[1,3] However, PNETs account for a disproportionate number of neuroendocrine liver metastases, which are seen on presentation in an estimated 60% of patients with PNETs, compared with 27% of all patients with GEP NETs?and the lifelong incidence of ...

 


Fulvestrant in the Era of CDK4/6 Inhibitors for HR+ mBC - OncLive



Fulvestrant in the Era of CDK4/6 Inhibitors for HR+ mBC 
OncLive
Joyce A. O'Shaughnessy, MD: I still do, and when patients benefit from CDK4/6 inhibitors first-line, I tend to go on to everolimus second-line, with the exception of liver metastases. In general, I have found patients seem to do better with ...

and more » 


Expert Addresses Ongoing Challenges in Melanoma - OncLive



OncLive
 
Expert Addresses Ongoing Challenges in Melanoma 
OncLive
I was invited to [Post-Chicago Melanoma] to talk about a couple different topics?one of them has to do with how to treat liver metastases for melanoma. It is a very difficult problem for a variety of reasons, one being that it is possible that the ...

 


Newlywed husband, 35, with incurable liver cancer in desperate bid to raise 30k for groundbreaking treatment - The Sun



The Sun
 
Newlywed husband, 35, with incurable liver cancer in desperate bid to raise 30k for groundbreaking treatment 
The Sun
A NEWLYWED wife has raised 22,000 to help her husband get treatment after he was diagnosed with a rare incurable liver cancer. Paul Phillips-Brame, 35, was admitted to hospital in March after doctors initially thought he had gall stones when he was ...
New bridegroom diagnosed with inoperable cancer is trying to raise 30000 for pioneering treatment not available on ... Daily Mail

all 2 news articles » 


Radiation+immunotherapy can slow tumor growth for some patients with metastatic NSCLC - Medical Xpress



Medscape
 
Radiation+immunotherapy can slow tumor growth for some patients with metastatic NSCLC 
Medical Xpress
Sequential radiation was given one week after the second immunotherapy cycle to a total radiation dose of 50 Gy delivered in four fractions, or 60 Gy in 10 fractions for larger lung or liver metastases?typically, those larger than four centimeters ...
Immunotherapy Plus RT for Metastatic Cancer: 'Step Forward' Medscape
In brief: ASTRO research round-up Medical Physics Web
Local RT Triples PFS in Metastatic NSCLC MedPage Today

all 44 news articles » 


Verzenio Granted Priority Review for Breast Cancer Treatment - Curetoday.com



Curetoday.com
 
Verzenio Granted Priority Review for Breast Cancer Treatment 
Curetoday.com
Verzenio (abemaciclib) was granted a priority review to a new drug application (NDA) to be used in combination with an aromatase inhibitor for the frontline treatment of women with hormone receptor (HR)-positive, HER2-negative advanced or metastatic ...

and more » 


FDA Grants Priority Review to Frontline Abemaciclib for HR+/HER2- Advanced Breast Cancer - OncLive



OncLive
 
FDA Grants Priority Review to Frontline Abemaciclib for HR+/HER2- Advanced Breast Cancer 
OncLive
The FDA has granted a priority review to a new drug application (NDA) for abemaciclib (Verzenio) for use in combination with an aromatase inhibitor for the frontline treatment of women with hormone receptor (HR)-positive, HER2-negative advanced or ...

and more » 


Thousands of bowel cancer patients denied life-saving treatment ... - The Sun



The Sun
 
Thousands of bowel cancer patients denied life-saving treatment ... 
The Sun
A recent study found more than half of patients with bowel cancer were not referred to surgery despite 75 per cent of those undergoing the op were still alive five ...
Bowel cancer patients 'being denied life-saving surgery' | Daily Mail ... Daily Mail

all 2 news articles »